NovMetaPharma Co., Ltd. (XKON:229500)
4,135.00
-75.00 (-1.78%)
At close: Oct 15, 2026
| Market Cap | 51.37B -69.1% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 33.33 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,876 |
| Open | 4,400.00 |
| Previous Close | 4,210.00 |
| Day's Range | 3,580.00 - 4,500.00 |
| 52-Week Range | 3,580.00 - 15,600.00 |
| Beta | 0.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |